Fisher Funds Lifesaver Trans Tasman Equity Fund
Lifesaver Trans Tasman Equity Fund is an aggressive KiwiSaver fund managed by Fisher Funds. It has 367 members and holds $33 million. It opened in 1992.
Fees and returns
- Annual fee
- 0.93% of your balance each year
- Return over 1 year
- −10.0% a year
- Return over 3 years
- +2.0% a year
- Return over 5 years
- +0.3% a year
Figures are after fees and tax, as at Q3 2026, sourced from the FMA Disclose Register.
What it invests in
Australasian equities 96%.
Largest holdings
- Buy Nzd:Sell Aud 11/05/26 11/05/2026 27.6%
- Buy Nzd:Sell Aud 05/06/26 05/06/2026 13.48%
- Fisher & Paykel Healthcare Corp Ltd 9.16%
Year by year
| Financial year | Return |
|---|---|
| 2025/26 | −10.0% |
| 2024/25 | +1.0% |
| 2023/24 | +16.9% |
| 2022/23 | −3.6% |
| 2021/22 | −1.0% |
| 2020/21 | +46.5% |
| 2019/20 | −0.7% |
| 2018/19 | +16.2% |
| 2017/18 | +11.7% |
| 2016/17 | +8.1% |
About this fund
The Fisher Funds LifeSaver Trans Tasman Equity Fund invests in New Zealand and Australian shares, giving concentrated regional (Trans-Tasman) equity exposure. It is a workplace savings scheme, joined through a participating employer. It has an annual fund charge of 0.93%.
See how all of Fisher Funds KiwiSaver's funds have performed